Columbia Laboratories to Hold First Quarter 2005 Financial Results Conference Call on May 10, 2005.LIVINGSTON, N.J. -- Columbia Laboratories, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : CBRX) will hold a conference call on May 10, 2005 to review financial results of the first quarter ended March 31, 2005. The call will be hosted by Fred Wilkinson, President and Chief Executive Officer, and David Weinberg, Chief Financial Officer, who will be joined by Steve Kasnet, Chairman of the Board of Columbia Laboratories, for the question and answer period.
Access information
Date: Tuesday, May 10, 2005
Time: 11:00 AM ET
U.S./Canada dial-in number: (800) 299-7089
International dial-in number: (617) 801-9714
Participant passcode: 49427251
Live webcast: www.columbialabs.com,
under the events tab
Replay Access Information A recording of the conference call will be available two hours after completion until May 17, 2005 at 11:59 PM ET at (888) 286-8010 (U.S.) and (617) 801-6888 (International). The replay password is 39444950. The webcast will be archived for on-demand listening for one year on Columbia Laboratories website, www.columbialabs.com. About Columbia Laboratories, Inc. Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to the development and commercialization of women's health care and endocrinology products, including those intended to treat infertility, dysmenorrhea dysmenorrhea Pain or cramps before or during menstruation. In primary dysmenorrhea, caused by endocrine imbalances, severity varies widely. Irritability, fatigue, backache, or nausea may also occur. , endometriosis and hormonal deficiencies and to prevent preterm preterm /pre·term/ (-term´) before completion of the full term; said of pregnancy or of an infant. pre·term adj. birth. Columbia markets Striant(R) (testosterone buccal buc·cal adj. 1. Of, relating to, adjacent to, or in the direction of the cheek. 2. Of or relating to the mouth cavity. buccal system) for the treatment of hypogonadism Hypogonadism Definition Hypogonadism is the condition more prevalent in males in which the production of sex hormones and germ cells are inadequate. in men, Prochieve(R) 8% (progesterone gel) for progesterone supplementation as part of an Assisted Reproductive Technology Assisted reproductive technology (ART) is a general term referring to methods used to achieve pregnancy by artificial or partially artificial means. It is reproductive technology used in infertility treatment, which is the only application routinely used today of treatment for infertile women with progesterone deficiency, and Prochieve(R) 4% (progesterone gel) for the treatment of secondary amenorrhea. Columbia's products and product candidates utilize the company's bioadhesive drug delivery technology. The Company is investigating the potential utility of Prochieve 8% in the prevention of preterm birth and developing a vaginally-administered lidocaine lidocaine /li·do·caine/ (li´do-kan) an anesthetic with sedative, analgesic, and cardiac depressant properties, applied topically in the form of the base or hydrochloride salt as a local anesthetic; also used in the latter form as a product to treat dysmenorrhea and pelvic pain. The Company has developed a buccal delivery system for peptides. For more information, please visit www.columbialabs.com. Striant(R) and Prochieve(R) are registered trademarks of Columbia Laboratories, Inc. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion